An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C-Reference-Cited by-同舟云学术

An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C

Published:2014-09 Issue:9 Volume:46 Page:818-825
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Andriulli Angelo,Nardi Alessandra,Di Marco Vito,Ippolito Antonio Massimo,Gavrila Caius,Aghemo Alessio,Di Paolo Daniele,Squadrito Giovanni,Grassi Eleonora,Calvaruso Vincenza,Valvano Maria Rosa,Brancaccio Giuseppina,Craxi Antonio,Angelico Mario,Raimondo Giovanni,Milella Michele,Morisco Filomena,Fattovich Giovanna,Felder Martina,Smedile Antonina,Fasano Massimo,Gatti Pietro,Andriulli Nicola,Tundo Paolo,Barone Michele,Cozzolongo Raffaele,D’Andrea Giovanna,Mazzella Giuseppe,Santantonio Teresa

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Boceprevir for untreated chronic HCV genotype 1 infection;Poordad;New England Journal of Medicine,2011

2. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;New England Journal of Medicine,2011

3. New direct-acting antiviral agents for the treatment of hepatitis C infection and perspectives;Welsch;Gut,2012

4. Anti hepatitis C virus drugs in development;Schaefer;Gastroenterology,2012

5. Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial;Mangia;Hepatology,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy;Frontiers in Pharmacology;2020-11-13

2. Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals;Pharmacogenomics and Personalized Medicine;2017-03

3. Impact ofIFNL4rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C;Journal of Clinical Laboratory Analysis;2016-10-13

4. The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin;Clinical and Experimental Hepatology;2016

5. Prediction of linear B-cell epitopes of hepatitis C virus for vaccine development;BMC Medical Genomics;2015-12